Edward Mezerhane, MD
Sleep Medicine · Miami, FLNPI 1063654218
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $368,520 of the $537,329 with a category attached, or 68.6%. 19 manufacturers reported payments, led by Jazz Pharmaceuticals Inc. at 57.4% of the total. 2025 is the largest year on record at $147,790, 2.3 times the $64,264 reported in 2019. Among sleep medicine clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 828 payments — averaging $648.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Jazz Pharmaceuticals Inc.$308K
- Harmony Biosciences LLC$68K
- Lilly USA, LLC$64K
- Axsome Therapeutics, Inc.$31K
- Avadel CNS Pharmaceuticals, LLC$31K
- Idorsia Pharmaceuticals US Inc$16K
- plus $18K from 13 others
Across 499 payments — averaging $2794.39 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Jazz Pharmaceuticals Inc.$504K
- Livanova USA, Inc.$447K
- Alkermes, Inc.$150K
- Avadel CNS Pharmaceuticals, LLC$130K
- Harmony Biosciences LLC$103K
- Vanda Pharmaceuticals Inc.$30K
- plus $30K from 3 others
What the payments were for
- Consulting fees$108,16820%
- Speaking & faculty fees$368,52069%
- Travel & lodging$40,5378%
- Food & beverage$19,8724%
- Education$2320%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Jazz Pharmaceuticals Inc. | 452 | $308,478 |
| Harmony Biosciences LLC | 107 | $67,704 |
| Lilly USA, LLC | 87 | $64,384 |
| Axsome Therapeutics, Inc. | 31 | $31,379 |
| Avadel CNS Pharmaceuticals, LLC | 40 | $30,662 |
| Idorsia Pharmaceuticals US Inc | 29 | $16,492 |
| Eisai Inc. | 37 | $11,466 |
| Eli Lilly | 3 | $2,700 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $2,040 |
| Inspire Medical Systems, Inc. | 4 | $666 |
| Fisher & Paykel Healthcare Inc | 10 | $578 |
| Resmed Corp | 8 | $192 |
| Medtronic(2 entities) | 2 | $149 |
| GSK | 1 | $115 |
| Avadel Specialty Pharmaceuticals, LLC | 1 | $112 |
| Livanova USA, Inc. | 1 | $104 |
| Arbor Pharmaceuticals, Inc. | 3 | $48 |
| Azurity Pharmaceuticals, Inc. | 2 | $43 |
| Itamar Medical Inc | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$537,329 in reported general payments places this provider in the 95th percentile of 77 sleep medicine providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Mirtazapine | 13 | $367 |
| Clonazepam | 20 | $301 |
| Trazodone Hcl | 26 | $127 |
| Ropinirole Hcl | 12 | $65 |
Paid to pharmacies, not to this prescriber.
Other sleep medicine in Miami
- Sergio JaramilloMiami$32K
- Carlos Ramirez MejiaMiami$25K
- Harneet WaliaMiami$19K
- Alberto RamosMiami$8K
- Rosa GarciaMiami$3K
- Ghaith ShukriMiami$2K
- Salim DibMiami$2K
- Dionne MorganMiami$797
- Jeremy McConnellBradenton$615K
- Shane DrahosWinter Garden$317K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.